Johnny Ludvigsson, Professor
Linkoeping University · Crown Princess Victoria Children´s Hospital and Linköping University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Johnny Ludvigsson, Professor as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:18 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT05351879 · Evaluation of a Booster Administration of GAD-alum (Diamyd®) in Individuals With Type 1 DiabetesLinkoeping University · completed · Diabetes Mellitus, Type 1 · principal investigator
- Ph3NCT05018585 · A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 DiabetesDiamyd Medical AB · terminated · Type 1 Diabetes Mellitus · principal investigator
- Ph1NCT02352974 · GAD-Alum (Diamyd) Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes (DIAGNODE-1)Johnny Ludvigsson · completed · Diabetes Mellitus, Type 1 · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:18 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.